Search results
Human babesiosis is a zoonotic infection caused by Babesia parasites transmitted by the bite of ixodid ticks that have distinct geographical distributions based on the presence of their competent natural animal hosts, which include rodents, cattle and deer.
30 lis 2020 · III. What Are the Preferred Treatment Regimens for Babesiosis? Recommendation: We recommend treating babesiosis with the combination of atovaquone plus azithromycin or the combination of clindamycin plus quinine (strong recommendation, moderate-quality evidence).
— The currently recommended treatment of human babesiosis is parenteral administration of clindamycin, 1,200 to 2,400 mg in three or four divided doses daily, and quinine, 650 mg every 6 to 8 hours daily; both drugs are given for 7 to 10 days.
Babesiosis is a zoonotic disease of humans caused by the hemoprotozoan piroplasm parasite “ Babesia.” The primary reservoir hosts are usually the rodents, primarily the white-footed mice.
30 lis 2020 · A new evidence-based clinical practice guideline for the prevention, diagnosis and treatment of the worldwide disease caused by Babesia parasites has been published in Clinical Infectious Diseases.
21 paź 2024 · Babesiosis is a blood-borne disease found mainly in the United States caused by a parasitic piroplasm. While most infections are mild to moderate in immunocompetent hosts, life-threatening complications can occur in those with significant comorbidities like congestive heart failure (CHF) or chronic obstructive pulmonary disease (COPD).
21 cze 2012 · This review article discusses the epidemiology, transmission, clinical manifestations, parasite life cycle, immunology, diagnosis, and treatment of babesiosis, a tickborne zoonosis.
